Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Lung Cancer. 2013 Dec;82(3):436–440. doi: 10.1016/j.lungcan.2013.10.001

Table 2.

Overall and Progression-Free Survival Status (N=100) by Protocol

# Death /#Failure Median (months) (95%CI)

CALGB
30002
(N=34)
CALGB
30206
(N=57)
CALGB
39808
(N=9)
All 3
Studies
(N=100)
CALGB 30002 CALGB 30206 CALGB
39808

All 3
Studies
Overall Survival 26 42 8 76 21.2
(16.2, 47.5)
21.2
(16.8, 29.4)
35.1
(10.3,56.5)
22.6
(18.5,29.4)
Progression-free Survival 26 45 8 79 13.6
(10.6, 23.6)
13.3
(11.6,16.7)
19.0
(3.5,53.2)
13.9
(12.6,16.7)